Stockreport

ARKG: Massive Potential, But Not Worth The Risk Yet For These 3 Reasons [Seeking Alpha]

CRISPR Therapeutics AG - Common Shares  (CRSP) 
Last crispr therapeutics ag - common shares earnings: 8/7 05:01 pm Check Earnings Report
US:NASDAQ Investor Relations: nasdaq.com/symbol/crsp/real-time
PDF ARKG has a relatively high expense ratio with no dividend yield, and its performance has significantly underperformed the S&P 500 Index. The fund's holdings are conce [Read more]